European Monitoring Centre for Drugs and Drug Addiction. (2016) Drug-related infectious diseases in Europe: update from the EMCDDA expert network. Lisbon: Publications Office of the European Union. 10.2810/139972.
Preview | Title | Contact |
---|---|---|
|
PDF (Drug-related infectious diseases in Europe)
- Published Version
681kB |
This report provides an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area. The report is based on the indicator’s annual expert meeting, held in Lisbon in June 2016, which brought together national experts from the 28 EU Member States, Norway and Turkey.
- Introduction and objective of this report
- Overview of the current situation: prevalence and trends in injecting, HIV and HCV infections
- Tailoring infectious disease prevention measures to the needs of vulnerable groups
- HCV treatment and continuum of care
- Drug-related infectious disease news and updates
- References and further reading
- Acknowledgements
- Resources
- Appendixes
B Substances > Opioids (opiates)
G Health and disease > Disease by cause (Aetiology) > Needle (sharing / injecting)
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > HIV
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Hepatitis B (HBV)
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Hepatitis C (HCV)
J Health care, prevention, harm reduction and treatment > Harm reduction > Substance use harm reduction
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control
VA Geographic area > Europe
Repository Staff Only: item control page